(Q35701591)

9 August 2017

1 reference

title

Chlamydia pneumoniae--an infectious risk factor for atherosclerosis? (English)

1 reference

9 August 2017

0 references

1 reference

Chlamydia pneumoniae

1 reference

Lee Ann Campbell

1

1 reference

9 August 2017

Cho-cho Kuo

series ordinal

2

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

Nature Reviews Microbiology

9 August 2017

published in

1 reference

9 August 2017

volume

2

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

23-32

1 reference

Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Background and current knowledge of Chlamydia pneumoniae and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Chlamydia trachomatis glycosaminoglycan-dependent and independent attachment to eukaryotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Mannose-receptor positive and negative mouse macrophages differ in their susceptibility to infection by Chlamydia species

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Heparan sulfate-like glycosaminoglycan is a cellular receptor for Chlamydia pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Global Stage-Specific Gene Regulation during the Developmental Cycle of Chlamydia trachomatis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Chlamydia trachomatis infection alters host cell transcription in diverse cellular pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Mortality by cause for eight regions of the world: Global Burden of Disease Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Structure and function of adhesion receptors in leukocyte trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Chlamydia pneumoniae and atherosclerosis -- what we know and what we don't

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Chlamydia pneumoniae serology: interlaboratory variation in microimmunofluorescence assay results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Detection of Chlamydia pneumoniae in arterial tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Chlamydia pneumoniae in atherosclerotic tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Chlamydia pneumoniae in atherosclerotic and nonatherosclerotic tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Poor correlation between microimmunofluorescence serology and polymerase chain reaction for detection of vascular Chlamydia pneumoniae infection in coronary artery disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Association of circulating Chlamydia pneumoniae DNA with cardiovascular disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Monocyte-endothelial cell coculture enhances infection of endothelial cells with Chlamydia pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Cell-to-cell contact of human monocytes with infected arterial smooth-muscle cells enhances growth of Chlamydia pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Chlamydia pneumoniae-infected monocytes exhibit increased adherence to human aortic endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Expression of adhesion molecules on endothelial cells stimulated by Chlamydia pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

cDNA array analysis of altered gene expression in human endothelial cells in response to Chlamydia pneumoniae infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Chlamydia pneumoniae infection of endothelial cells induces transcriptional activation of platelet-derived growth factor-B: a potential link to intimal thickening in a rabbit model of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Interactions of Chlamydia pneumoniae with human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Hydroxymethylglutaryl coenzyme A reductase inhibition reduces Chlamydia pneumoniae-induced cell interaction and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Hydroxymethylglutaryl coenzyme A reductase inhibitors modify the inflammatory response of human macrophages and endothelial cells infected with Chlamydia pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Chlamydial virulence determinants in atherogenesis: the role of chlamydial lipopolysaccharide and heat shock protein 60 in macrophage-lipoprotein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Foam cell formation inhibits growth of Chlamydia pneumoniae but does not attenuate Chlamydia pneumoniae-induced secretion of proinflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Upregulation of extracellular matrix metalloproteinase inducer (EMMPRIN) and gelatinases in human atherosclerosis infected with Chlamydia pneumoniae: the potential role of Chlamydia pneumoniae infection in the progression of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Chlamydia pneumoniae induces tissue factor expression in mouse macrophages via activation of Egr-1 and the MEK-ERK1/2 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Pathways of Egr-1-mediated gene transcription in vascular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Atherosclerosis in apoE knockout mice infected with multiple pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Chlamydia pneumoniae infection accelerates hyperlipidemia induced atherosclerotic lesion development in C57BL/6J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Influence of clarithromycin on early atherosclerotic lesions after Chlamydia pneumoniae infection in a rabbit model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Chlamydia pneumoniae does not increase atherosclerosis in the aortic root of apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Chlamydia pneumoniae induces inflammatory changes in the heart and aorta of normocholesterolemic C57BL/6J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Chlamydia pneumoniae and hyperlipidemia are co-risk factors for atherosclerosis: infection prior to induction of hyperlipidemia does not accelerate development of atherosclerotic lesions in C57BL/6J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Chlamydia pneumoniae induces neointima formation in coronary arteries of normal pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Endothelial dysfunction after repeated Chlamydia pneumoniae infection in apolipoprotein E-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Acute Chlamydia pneumoniae infection causes coronary endothelial dysfunction in pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Effect of short-term antibiotic treatment on Chlamydia pneumoniae and peripheral endothelial function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Chlamydia pneumoniae infection induces an unstable atherosclerotic plaque phenotype in LDL-receptor, ApoE double knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Effects of two antibiotic regimens on course and persistence of experimental Chlamydia pneumoniae TWAR pneumonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Antibiotics effects in a rabbit model of Chlamydia pneumoniae-induced atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Antibiotic treatment of atherosclerotic cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Exercise training in coronary artery disease and coronary vasomotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Chlamydia pneumoniae sp. nov. for Chlamydia sp. Strain TWAR

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Proposal of Chlamydia pecorum sp. nov. for Chlamydia strains derived from ruminants

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Mechanism of C. trachomatis attachment to eukaryotic host cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

An N-linked high-mannose type oligosaccharide, expressed at the major outer membrane protein of Chlamydia trachomatis, mediates attachment and infectivity of the microorganism to HeLa cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Chlamydia pneumoniae (TWAR).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

PECAM-1 is required for transendothelial migration of leukocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Potential infectious etiologies of atherosclerosis: a multifactorial perspective

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Virus-induced atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Chlamydial infections of the cardiovascular system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Induction of macrophage foam cell formation by Chlamydia pneumoniae

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Murine models of Chlamydia pneumoniae infection and atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Serological response to Chlamydia pneumoniae in patients with sarcoidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

Identification of a new group of Chlamydia psittaci strains called TWAR.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

7 January 2021

In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

7 January 2021

Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

7 January 2021

Growth of Chlamydia pneumoniae induces cytokine production and expression of CD14 in a human monocytic cell line

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

7 January 2021

Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits.

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO796

7 January 2021

Identifiers

DOI

10.1038/NRMICRO796

1 reference

Dimensions Publication ID

9 August 2017

1016395975

0 references

1 reference